Download PDF
Endoscopy 2007; 39(1): 24-29
DOI: 10.1055/s-2006-945182
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus

M.  Ciocirlan1, 2 , M.  G.  Lapalus2 , V.  Hervieu3 , J.  C.  Souquet2 , B.  Napoléon2 , J.  Y.  Scoazec3 , C.  Lefort2 , J.  C.  Saurin2 , T.  Ponchon2
  • 1Gastroenterology and Hepatology Centre, Fundeni Clinical Institute, Bucharest, Romania
  • 2Hépatogastroentérologie, Hôpital Édouard Herriot, Lyon, France
  • 3Laboratoire Central d’Anatomie Pathologique, Hôpital Édouard Herriot, Lyon, France
Further Information

Publication History

submitted 25 June 2006

accepted after revision 4 December 2006

Publication Date:
25 January 2007 (online)

Also available at
    Permissions and Reprints

See also:

Commentaire de travail de M. CiocirlanR et al., pp. 24Endoscopy 2007; 39(01): 191-191
DOI: 10.1055/s-0032-1306907

Background and study aims: Endoscopic mucosal resection (EMR) is used to treat premalignant and malignant digestive tract lesions. This report presents the efficacy and safety of EMR for squamous superficial neoplastic esophageal lesions. Patients and methods: A retrospective cohort study presented data from 51 patients with 54 lesions over an 8-year period, between November 1997 and September 2005. Dysplasias or mucosal (m) T1 carcinomas were treated with repeated EMR until there was complete local remission. Patients with submucosal (sm) T1 carcinomas or more advanced stage were offered surgery or chemoradiotherapy. Results: There was no mortality, perforation, or major hemorrhage, and there were three easily dilated stenoses. Of the patients, 16 had lesions graded as T1sm or more advanced and one patient was found to have normal tissue post EMR. Complete local remission was achieved in 31 of the 34 patients with dysplasia or T1 m cancers (91 %). There was no distant relapse and there was local disease recurrence in eight of the 31 patients (26 %). The 5-year survival rate was 58 %, while the disease specific 5-year survival rate was 95 %. Conclusions: EMR for squamous superficial neoplastic lesions of the esophagus is safe and provides satisfactory survival results.

References

  • 1 Makuuchi H, Machimura T, Sugihara T. et al . Endoscopic diagnosis and treatment of the mucosal carcinoma of the esophagus.  Endoscopia Digestiva. 1990;  2 447-452
    PubMedSearch in Google Scholar
  • 2 Makuuchi H, Machimura , Soh Y. et al . Endoscopic mucosectomy for mucosal carcinoma in the esophagus.  Jpn J Surg Gastroenterol. 1991;  24 2599-2603
    PubMedSearch in Google Scholar
  • 3 Makuuchi H, Machimura T, Mizutani K. et al .Endoscopic mucosal resection for early carcinomas of the esophagus. In: Takahashi T (ed.) Recent advances in management of digestive cancer. Tokyo; Springer Verlag 1993: 97
    Search in Google Scholar
  • 4 Inoune H, Tani M, Nagal K. et al . Treatment of esophageal and gastric tumors.  Endoscopy. 1993;  31 47-55
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Makuuchi H. Endoscopic mucosal resection for early esophageal cancer - indication and techniques.  Dig Endosc. 1996;  8 175-179
    PubMedSearch in Google Scholar
  • 6 Japanese Society for Esophageal Diseases .Guidelines for the clinical and pathological studies of carcinoma of the esophagus. Tokyo; Kanehara & Co 1999
    Search in Google Scholar
  • 7 Watanabe H, Jass J R, Sobin L H. Histological typing of esophageal and gastric tumors, 2nd edn. Berlin; Springer 1990
    Search in Google Scholar
  • 8 Schlemper R J, Riddell R H, Kato Y. et al . The Vienna classification of gastrointestinal epithelial neoplasia.  Gut. 2000;  51 AB120 (3537)
    PubMedSearch in Google Scholar
  • 9 Sano M, Okuda S, Tamura H. et al .Esophagoendoscopy using Lugol’s staining; diagnosis of esophageal cancer. In: Takemoto T, Kawai K, Ida K, Suzuki S (eds) Chromoendoscopy for gastrointestinal cancer. Tokyo; Igaku Shoin 1978: 13-24
    Search in Google Scholar
  • 10 Inoue H, Takeshita K, Hori H. et al . Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach and colon mucosal lesions.  Gastrointest Endosc. 1993;  39 58-62
    CrossrefPubMedSearch in Google Scholar
  • 11 Inoue H, Noguchi O, Saito N. et al . Endoscopic mucosal resection for early cancer using a pre-looped plastic cap.  Gastrointest Endosc. 1994;  40 263-264
    PubMedSearch in Google Scholar
  • 12 Inoue H. Endoscopic mucosal resection for esophageal and gastric mucosal cancers.  Can J Gastroenterol. 1998;  12 355-359
    PubMedSearch in Google Scholar
  • 13 Hamilton S R, Aaltonen L A (eds). WHO classification of tumors. Tumors of the digestive system. Lyon; IARC Press 2000
    Search in Google Scholar
  • 14 Bollschweiler E, Baldus S E, Schroder W. et al . High rate of lymph-node metastasis in submucosal esophageal squamous cell carcinomas and adenocarcinomas.  Endoscopy. 2006;  38 149-156
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Shimada H, Nabeya Y, Matsubara H. et al . Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.  Am J Surg. 2006;  191 250-254
    CrossrefPubMedSearch in Google Scholar
  • 16 Eguchi T, Nakanishi Y, Shimoda T. et al . Histopathogical criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases.  Mod Pathol. 2006;  19 475-480
    CrossrefPubMedSearch in Google Scholar
  • 17 Huguier M, Flahault A. Biostatistiques au quotidien. Amsterdam; Elsevier 2000
    Search in Google Scholar
  • 18 Stein H J, Feith M, Bjorn L D. et al . Pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection.  Ann Surg. 2005;  242 566-575
    PubMedSearch in Google Scholar
  • 19 Tachibana M, Kinugasa S, Shibakita M. et al . Surgical treatment of superficial esophageal cancer.  Langenbecks Arch Surg. 2006;  391 304-321
    CrossrefPubMedSearch in Google Scholar
  • 20 Fujita H, Sueyoshi S, Yamana H. et al . Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophageactomy.  World J Surg. 2001;  25 424-431
    CrossrefPubMedSearch in Google Scholar
  • 21 Shimizu Y, Tsukagoshi H, Fujita M. et al . Long-term outcome alter endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper.  Gastrointest Endosc. 2002;  56 387-390
    CrossrefPubMedSearch in Google Scholar
  • 22 Pech O, Gossner L, May A. et al . Endoscopic resection of superficial esophageal squamous cell carcinomas: western experience.  Am J Gastroenterol. 2004;  99 1226-1232
    CrossrefPubMedSearch in Google Scholar
  • 23 Vieth M, Ell C, Gossner L. et al . Histological analysis of endoscopic resection from 326 patients with Barrett’s esophagus and early neoplasia.  Endoscopy. 2004;  36 776-781
    Thieme ConnectPubMedSearch in Google Scholar
  • 24 Narahara H, Iishi H, Tatsuta M. et al . Effectiveness of endoscopic mucosal resection with submucosal saline injection technique for superficial squamous carcinomas of the esophagus.  Gastrointest Endosc. 2000;  52 730-734
    CrossrefPubMedSearch in Google Scholar
  • 25 Nomura T, Boku N, Ohtsu A. et al . Recurrence after endoscopic mucosal resection for superficial esophageal cancer.  Endoscopy. 2000;  32 277-280
    Thieme ConnectPubMedSearch in Google Scholar
  • 26 Katada C, Muto M, Manabe T. et al . Local recurrence of squamous-cell carcinoma of the esophagus after EMR.  Gastrointest Endosc. 2005;  61 219-225
    CrossrefPubMedSearch in Google Scholar
  • 27 Bradburn M J, Clark T G, Love S B. et al . Survival analysis part III: multivariate data analysis - choosing a model and assessing its adequacy and fit.  Br J Cancer. 2003;  89 605-611
    CrossrefPubMedSearch in Google Scholar
  • 28 Peduzzi P, Concato J, Feinstein A R. et al . Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimates.  J Clin Epidemiol. 1995;  48 1503-1510
    CrossrefPubMedSearch in Google Scholar

M. Ciocirlan, MD

Hépatogastroentérologie
Hôpital Édouard Herriot

5 Place d’Arsonval
69437, Lyon
France

Email: ciocirlanm@yahoo.com